Stryker Corp. (SYK) Company Profile & Statistics

Stryker Corp.
SYK
(NYSE)
Closed
390.05
+4.37 (+1.13%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
386.15
High
390.38
Low
384.78

About Stryker Corp.

CEO

Kevin A. Lobo

Headquarters

1941 stryker way

portage, mi 49002, united states

Auditor

Ernst & Young LLP

Employees

52,000

Share Holders

2,501

Website

www.strykercorp.com

Industry

medical specialties

Sector

health technology

Company Overview

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Stryker Corp. Statistics

Valuation Measures

Market Capitalization ²	148.69B
Enterprise Value	160.33B
Enterprise Value/EBITDA (ttm)	29.69
Price to Earnings Ratio (ttm)	33.39
Price to Book (mrq)	7.35
Price to Sales (ttm)	6.74
Price to Cash (ytd)	28.99

Profitability

Gross Margin (ttm)	63.57%
Operating Margin (ttm)	20.39%
Profit Margin (ttm)	16.27%
Return on Equity (ttm)	23.07%
Return on Invested Capital (ttm)	11.76%
Return on Assets (ttm)	11.04%

Income Statement

Revenue (ttm)	21.97B
Revenue Per Share (ttm)	57.64
Gross Profit (ttm)	13.97B
EBITDA (ttm)³	5.40B
Net Income Avi to Common (ttm)	3.59B
Diluted EPS (ttm)	9.33

Share Statistics

Beta (5Y Monthly)	0.91
52-Week Change	36.12%
S&P500 52-Week Change	30.55%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	381.22M
Dividend Yield	0.82%
Float ⁴	358.72M
% Held by Insiders	5.90%
% Held by Institutions	77.09%

Balance Sheet

Total Cash (mrq)	4.68B
Total Cash Per Share (mrq)	12.29
Total Debt (mrq)	15.48B
Total Debt/Equity (mrq)	76.85%
Current Ratio (mrq)	1.91%
Quick Ratio (mrq)	1.22%
Book Value Per Share (mrq)	52.87

Cash Flow

Operating Cash Flow Per Share (ytd)	5.99
Free Cash Flow (ytd)	1.82B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Stryker Corp.

Trade With A Regulated Broker